spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Oncology

 HSMN NewsFeed - 31 May 2016
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 May 2016
New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinoma
Devices Oncology
 HSMN NewsFeed - 26 May 2016
Third Installation of Elekta’s High-Field MR-Guided Linear Accelerator Underway at University Medical Centre Utrecht
Devices Oncology
 HSMN NewsFeed - 25 May 2016
Elekta Wins Public Tender to Deliver Advanced Cancer Care Solutions to New Karolinska Solna (NKS)
Devices Oncology Neurosurgery
 HSMN NewsFeed - 23 May 2016
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
Diagnostic Gastroenterology Oncology
 HSMN NewsFeed - 23 May 2016
OncoSec Announces $10 Million At-The-Market Registered Direct Offering
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 May 2016
Elekta Surpasses One Million Patients Treated with Leksell Gamma Knife
Devices Oncology Neurosurgery
 HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Diagnostics Devices Oncology
 HSMN NewsFeed - 17 May 2016
Nouscom Concludes Successful Series A Financing of EUR 12 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 May 2016
Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 9 May 2016
U.S. FDA Expands IMBRUVICA(R) (ibrutinib) Label to Include Overall Survival Data in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and New Indication for Small Lymphocytic Lymphoma (SLL) Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 May 2016
Epizyme Continues to Build Senior Leadership Team with Appointment of Matthew Ros as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 May 2016
ACT Genomics Raises $12.5 Million In Series B Funding
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 3 May 2016
Bioniz Therapeutics Appoints Fredrik Wiklund as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2016
XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2016
Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016
Diagnostics Oncology
 HSMN NewsFeed - 2 May 2016
EndoChoice(R) Announces William Enquist as New Chairman of the Board
Devices Gastroenterology Oncology Personnel
 HSMN NewsFeed - 2 May 2016
Enhanced Cystoscopy including Blue Light Cystoscopy with Cysview(R)/Hexvix(R) is Recommended in the New AUA/SUO Bladder Cancer Guideline
Biopharmaceuticals Diagnostics Urology Oncology
 HSMN NewsFeed - 2 May 2016
Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife(R) System
Devices Oncology
 HSMN NewsFeed - 29 Apr 2016
Elekta's Latest Monaco Release Features Up to Four Times Faster Calculation Speed for Reduced Radiotherapy Planning Times
Devices Oncology Product Launch
 HSMN NewsFeed - 28 Apr 2016
Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35
Devices Oncology
 HSMN NewsFeed - 27 Apr 2016
Proton Therapy Center Initiates 3D Image Guided Proton Therapy to Enhance Precision of Cancer Care
Devices Oncology
 HSMN NewsFeed - 26 Apr 2016
MD Anderson Cancer Center to Acquire Elekta Linear Accelerators and Other Radiotherapy Solutions
Devices Oncology
 HSMN NewsFeed - 26 Apr 2016
Hematogenix Laboratory Services, LLC (Hematogenix)- Announces the Launch of two U.S. Food and Drug Administration (FDA) Approved PD-L1 Companion Diagnostic Tests to Help Guide Oncologists Using Immuno-Oncology Therapies
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Apr 2016
Celator(R) Pharmaceuticals Announces Positive Results Demonstrating Reduced Healthcare Resource Use with VYXEOS(TM) Compared to Standard Treatment for Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Apr 2016
Elekta to Demonstrate Market-leading Radiosurgery Solutions and Innovations at ESTRO 35
Devices Oncology Neurosurgery
 HSMN NewsFeed - 22 Apr 2016
Accuray Hosts Regional AERO Users' Meeting
Devices Oncology
 HSMN NewsFeed - 21 Apr 2016
FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Apr 2016
Hologic Announces FDA Clearance and Commercial Availability of the Affirm(TM) Prone Biopsy System, the First 2D/3D(TM) Imaging-Guided Dedicated Prone Biopsy System
Devices Oncology Radiology FDA Product Launch
 HSMN NewsFeed - 20 Apr 2016
John Lapré to Fulfill Role as Elekta’s Chief Technology Officer
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 18 Apr 2016
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 18 Apr 2016
Elekta and Philips Begin Installation of MR-Guided Linear Accelerator at The Netherlands Cancer Institute
Devices Oncology Radiology
 HSMN NewsFeed - 14 Apr 2016
RefleXion Medical Raises $46 Million Series B Financing Led by KCK Group
Devices Oncology Venture Capital Personnel
 HSMN NewsFeed - 13 Apr 2016
Richard Hausmann Appointed as Elekta's President and CEO
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 11 Apr 2016
FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer
Biopharmaceuticals Personalized Medicine Oncology FDA
 HSMN NewsFeed - 7 Apr 2016
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 6 Apr 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Diagnostics Oncology Regulatory
Older Oncology stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!